Which of the following statements regarding the HPV vaccine is correct?

AIIMS Rishikesh NO - 2019

Pharmacology

Easy

Appeared in: AIIMS Rishikesh NO - 2019

Explanation

The primary target for HPV vaccination is adolescents aged 9–14 years.
Vaccination is most immunogenic and effective when administered before the onset of sexual activity and potential exposure to HPV.
This strategy maximizes the prevention of HPV-related cancers, such as cervical, anal, and oropharyngeal cancers.
The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination at age 11 or 12, with the option to start as early as age 9.

Option A: While the World Health Organization (WHO) has recently suggested that a single dose may be an effective alternative, the standard recommended schedule for the 9-14 age group has been two doses. This statement is not the most established or universally applied guideline.
Option B: This statement contains two errors. The HPV vaccine is a recombinant vaccine made of virus-like particles (VLPs); it is not a live virus. Additionally, it protects against the most common cancer-causing HPV types (like 16 and 18) but not all of the over 100 HPV variants.
Option D: This is a public health target set by the WHO as part of its 90-70-90 global strategy to eliminate cervical cancer. It is a goal for healthcare systems, not a clinical fact or guideline regarding the vaccine's administration or properties.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain HPV Vaccination Guidelines as background academic context rather than a clinical decision trigger.
Nurses play a crucial role in educating parents, guardians, and adolescents about the importance, safety, and timing of the HPV vaccine to increase uptake rates.
Addressing misconceptions, such as fears about safety or the belief that the vaccine is only for girls, is a key nursing responsibility.
What if? A 17-year-old who has not been vaccinated asks about the HPV vaccine. The nurse should explain that 'catch-up' vaccination is recommended for individuals up to age 26. For this age group, a three-dose series is required instead of the two-dose series for younger adolescents.

How to Approach the Question

First, identify that the question asks for a single correct statement among the options, requiring factual recall about the HPV vaccine.
Evaluate each option against established immunization guidelines.
Eliminate Option B immediately because it makes absolute claims ('live vaccine', '100% protective', 'all variants') which are rarely true in medicine. The HPV vaccine is recombinant.
Differentiate between a clinical guideline and a public health goal. Option D describes the WHO's 90% vaccination coverage goal, which is a target, not a property of the vaccine.
Compare the remaining options. Option C states the primary target age (9-14 years), which is a fundamental and long-standing recommendation for maximizing vaccine efficacy. Option A discusses a one-dose schedule, which is a more recent and alternative guideline. Therefore, the primary target age is the most robust and correct statement.

Concept Tested & Keywords

QHsXrcrS1CvFkVVoEM0kt3

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 201-203

E6 Gynecology Williams p. 211-252